Momordica charantia: A natural medicinal plant

Authors

  • Vani Chekka Satya Department of Pharmacology, Jawaharlal Nehru Technological University-Kakinada (JNTUK), India.
  • Kumar Mantipelly Naresh Department of Pharmacology, Jawaharlal Nehru Technological University-Kakinada (JNTUK), India.

DOI:

https://doi.org/10.30574/gscbps.2020.12.2.0251

Keywords:

Momordica charantia, bitter melon, antidiabetic, wound healing, antimicrobial, anticancer

Abstract

Natural products play an important role in the treatment of several diseases inflicted on mankind and in drug discovery procedures. Drugs synthesized from naturally available products are usually safe, cheap in cost, easily available and more effective than pure synthetic drugs in the treatment of several diseases. Bitter melon containing numerous bioactive compounds like saponins, alkaloids, polypeptides, minerals, vitamins, with the ability to fight against several disorders, i.e. diabetes mellitus, abdominal pain, tumor proliferation, cancer, kidney (stone), scabies and fever. The key constituent of BM called charantin, which is steroidal saponins, act like peptides and certain alkaloids that control sugar levels in blood. The medicinal properties of M.charantia are beneficial in regulating blood cholesterol to minimise cardiovascular disorders like atherosclerosis. There are several classes of secondary metabolites, such as tannins, flavonoids, and alkaloids in the fresh and dried leaves extracts of Bitter melon with antimicrobial activity. This phytochemical composition of both the leaves reported antimicrobial activity against different bacteria, like Salmonella, E. coli, Pseudomonas aeruginosa, Bacillus and Streptococcus

Metrics

Metrics Loading ...

References

Farhan S, Muhammad A, Bushra N, Muhammad UA, Tabussam T, Muhammad BH and Ahsan J. Bitter melon (Momordica charantia): a natural healthy vegetable.

Patience OO, Estella UO and Philip FU. Natural Products as Potential Sources of Antidiabetic Drug.

Nirupama KV, J Adlin Jino Nesalin and T Tamizh M. Extraction, Isolation and Characterization of charantin From Momordica charantia Fruit.

Grossmann ME, Mizuno NK, Dammen ML, Schuster T, Ray A and Cleary MP. Eleostearic Acid Inhibits Breast Cancer Proliferation by Means of an Oxidation-Dependent Mechanism. Cancer Prevention Research.

Liu XR, Deng ZY, Fan YW, Li J and Liu ZH. Mineral Elements Analysis of Momordica charantiap Seeds by ICP-AES and Fatty Acid Profile Identification of Seed Oil by GC-MS. Guang Pu Xue Yu Guang Pu Fen Xi.

Popovich DG, Li L and Zhang W. Bitter Melon (Momordica charantia) Triterpenoid Extract Reduces Preadipocyte Viability, Lipid Accumulation and Adiponectin Expression in 3T3-L1 Cells. Food and Chemical Toxicology.

Mesia GK Tona GL Nanga TH Cimanga RK, Apers S, Cos P, Maes L, Pieters L and Vlietinck AJ. Antiprotozoal and Cytotoxic Screening of 45 Plant Extracts from Democratic Republic of Congo. Journal of Ethnopharmacology.

Ahmad Z, Zamhuri KF, Yaacob A, Siong CH, Selvarajah M, Nazrul IA and Hakim M. In Vitro AntiDiabetic Activities and Chemical Analysis of Polypeptide-K and Oil Isolated from Seeds of Momordica charantia (Bitter Gourd).

Hsu C, Hsieh CL, Kuo YH and Huang CJ. Isolation and Identification of Cucurbitane-Type Triterpenoids with Partial Agonist/Antagonist Potential for Estrogen Receptors from Momordica charantia. Journal of Agricultural and Food Chemistry.

Tan SP, Stathopoulos C, Parks S and Roach P. An Optimised Aqueous Extract of Phenolic Compounds from Bitter Melon with High Antioxidant Capacity. Antioxidants (Basel).

Horax R, Hettiarachchy N, Over K, Chen P and Gbur E. Extraction, Fractionation and Characterization of Bitter Melon Seed Proteins. Journal of Agricultural and Food Chemistry.

Snee LS, Nerurkar VR, Dooley DA, Efird JT, Shovic AC and Nerurkar PV. Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): A vegetable commonly used for diabetes management.

Ahmad N, Hassan MR, Halder H, et al. Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients.

Jayasooriya AP, Sakono M, Yukizaki C, et al. Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets.

Murray MT. The Healing Power of Herbs: The Enlightended Person's Guide to the Wonders of Medicinal Plants.

Leatherdale BA, Panesar RK, Singh G, et al. Improvement in glucose tolerance due to Momordica charantia.

Madhu Guptha. Momordica charantia: Nature’s silent healer.

Lolitkar MM, et al. Pharmacology of a hypoglycaemic principle isolated from the fruits of Momordica charantia. Linn.

Anti-diabetic Activity of Momordica charantia or Bitter Melon: A Review Ranabir Chanda1, Asim Samadder2 and Janmajoy Banerjee.

Brandao DO, Guimaraes GP, Santos RL, Junior FJ, Da Silva KM, De Souza FS and Macedo RO. Model Analytical Development for Physical, Chemical, and Biological Characterization of Momordica charantia Vegetable Drug.

Gupta S, Raychaudhuri B, Banerjee S, Das B, Mukhopadhaya S and Datta SC. Momordicatin Purified from Fruits of Momordica charantia Is Effective to Act as a Potent Antileishmania Agent

Olasehinde GI, Ojurongbe O, Adeyeba AO, Fagade OE, Valecha N, Ayanda IO, Ajayi AA and Egwari LO. In Vitro Studies on the Sensitivity Pattern of Plasmodium Falciparum to Anti-Malarial Drugs and Local Herbal Extracts.

Aljohi A, Matou-Nasri S and Ahmed N. Antiglycation and Antioxidant Properties of Momordica charantia.

Qader SW, Abdulla MA, Chua LS, Najim N, Zain MM and Hamdan S. Antioxidant, Total Phenolic Content and Cytotoxicity Evaluation of Selected Malaysian Plants. Molecules.

Sathishsekar D and Subramanian S. Antioxidant properties of Momordica charantia (bitter gourd) seeds on Streptozotocin induced diabetic rats.

Fang EF, Zhang CZY, Wong JH, Shen JY, Li CH and Ng TB .The MAP30 protein from bitter gourd Momordica charantia seeds promotes apoptosis in liver cancer cells in vitro and in vivo.

Grover JK and Yadav SP. Pharmacological actions and potential uses of Momordica charantia: A review.

Nutritional, pharmacological and medicinal properties of Momordica charantia Kandangath Raghavan Anilakumar, Garlapati Phani Kumar, Nallamuthu Ilaiyaraja.

Bourinbaiar AS and Lee-Huang S. Potentiation of anti-HIV activity of the anti-inflammatory drugs dexamethasone and indomethacin by MAP30, the antiviral agent from bitter melon.

Zhang QC. Preliminary report on the use of Momordica charantia extract by HIV patients.

Gupta S, Raychaudhuri B, Banerjee S, Das B, Mukhopadhaya S and Datta SC. Momordicatin purified from fruits of Momordica charantia is effective to act as a potent antileishmania agent.

Balboa JG and Lim-Sylianco CY. Antigenotoxic effects of drug preparations Akapulko and Ampalaya.

Hussan F, Teoh SL, Muhamad N, Mazlan M and Latiff AA. Momordica charantia Ointment Accelerates Diabetic Wound Healing and Enhances Transforming Growth factor-β Expression.

Subhashchandra P, Tushar P, Kaushal P, Yagnesh B, Yogesh P and Dr. NM Patel. Isolation, Characterization and antimicrobial activity of charantin from Momordica charantia fruit..

Singh MP. Sarangdevot Y.S. and Sisodia S.S. “Wound Healing Activity of the whole plant of Momordica charantia in Rats.

Sonal Desai, Pratima Tatke. Charantin: An important lead compound from Momordica charantia for the treatment of diabetes.

Rajaram P, Natarajan M and Ganesan VS. Wound healing property of aqueous extract of seed and outer layer of Momordica chara n tia L. on albino rats.

Nal Ae Y, Juyeong P, Jiyeon L, Joo YJ, HK, Hak SL, In GH, Gu SR, Hyun JK, Gyeong JC, Wan SC, Dong HL and Sang SK. Anti-diabetic Effects of Ethanol Extract from Bitter Melon in Mice Fed a High-fat Diet.

Soon YY and Tan BKH. Evaluation of the hypoglycaemic and anti- oxidant activities of Morinda officinalis in streptozotocin-induced diabetic rats. Singapore Med J.

Powers AC. Diabetes mellitus. In Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL (eds.), Harrison’s Principles of Internal Medicine, 26th Edition, McGraw-Hill Medical Publishing Division: New York.

Guo S and Di Pietro LA. Factors Affecting Wound Healing, J. Dent. Res.

Namsa ND, Mandal M, Tangjang S and Mandal SC. Ethnobotany of the Monpa Ethnic Group at Arunachal Pradesh, India. Journal of Ethnobiology and Ethnomedicine.

Puri R, Sud R, Khaliq A, Kumar M and Jain S. Gastrointestinal Toxicity Due to Bitter Bottle Gourd (Lagenaria Siceraria)–A Report of 15 Cases. Indian Journal of Gastroenterology.

Sabourian R, Karimpour-Razkenari E, Saeedi M, Bagheri MS, Khanavi M, Sadati N, Akbarzadeh T and Ardekani MR. Medicinal Plants Used in Iranian Traditional Medicine (ITM) as Contraceptive Agents. Current Trends Biotechnology Pharmacy.

KP Sampath Kumar. Debjit Bhowmik: Traditional medicinal uses and therapeutic benefits of Momordica charantia Linn.

Baby J and D Jini. Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency.

Monirul I, Md. Saiful I, Shaheda Z, Golam S and Mamunur R. Momordica charantia (Bitter melon) in Combination with Metformin Potentiates Hypoglycaemic and Hypolipidemic Effects in Alloxan-induced Diabetic Rats.

Downloads

Published

2022-02-04

How to Cite

Satya, V. C., & Naresh, . K. M. (2022). Momordica charantia: A natural medicinal plant. GSC Biological and Pharmaceutical Sciences, 12(2), 129–135. https://doi.org/10.30574/gscbps.2020.12.2.0251

Issue

Section

Review Article